KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Pacira BioSciences (PCRX) Equity Average: 2010-2024

Historic Equity Average for Pacira BioSciences (PCRX) over the last 15 years, with Dec 2024 value amounting to $824.2 million.

  • Pacira BioSciences' Equity Average fell 8.83% to $742.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $742.5 million, marking a year-over-year decrease of 8.83%. This contributed to the annual value of $824.2 million for FY2024, which is 0.20% up from last year.
  • According to the latest figures from FY2024, Pacira BioSciences' Equity Average is $824.2 million, which was up 0.20% from $822.6 million recorded in FY2023.
  • Over the past 5 years, Pacira BioSciences' Equity Average peaked at $824.2 million during FY2024, and registered a low of $487.3 million during FY2020.
  • Over the past 3 years, Pacira BioSciences' median Equity Average value was $822.6 million (recorded in 2023), while the average stood at $799.8 million.
  • Data for Pacira BioSciences' Equity Average shows a peak YoY skyrocketed of 44.14% (in 2020) over the last 5 years.
  • Over the past 5 years, Pacira BioSciences' Equity Average (Yearly) stood at $487.3 million in 2020, then spiked by 38.52% to $675.0 million in 2021, then climbed by 11.50% to $752.7 million in 2022, then rose by 9.28% to $822.6 million in 2023, then grew by 0.20% to $824.2 million in 2024.